股票 › RVMD
革命医药 RVMD
美股市值排名 #525
$192.28 +$14.63 (+8.24%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $194.38 +1.09%
开盘$184.87
昨收$177.65
当日区间$181.27 – $195.02
成交量4.50M
市值$41.59B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数23
平均目标价$270.32+40.6% 较现价
- 买入 100%
最低 $220.00现价 $192.28均值 $270.32最高 $350.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$222.00至$350.00，平均为$271.78。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 6 Nov 2026 | Morgan Stanley | BUY | $272.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $350.00 |
| 5 Nov 2026 | TD Cowen | BUY | $270.00 |
| 5 Nov 2026 | Piper Sandler | BUY | $222.00 |
| 5 Nov 2026 | BofA Securities | BUY | $274.00 |
| 5 Nov 2026 | Wedbush | BUY | $225.00 |
| 5 Nov 2026 | Morgan Stanley | BUY | $272.00 |
| 5 Nov 2026 | Evercore | BUY | $340.00 |
| 5 Nov 2026 | Stifel | BUY | $230.00 |
| 5 Nov 2026 | Oppenheimer | BUY | $260.00 |
| 5 Nov 2026 | RBC Capital | BUY | $321.00 |
| 4 Nov 2026 | Guggenheim | BUY | $298.00 |
| 4 Nov 2026 | J.P. Morgan | BUY | – |
| 27 Oct 2026 | RBC Capital | BUY | $260.00 |
| 26 Oct 2026 | BofA Securities | BUY | $264.00 |
| 22 Oct 2026 | UBS | BUY | $265.00 |
| 22 Oct 2026 | Morgan Stanley | BUY | $255.00 |
| 21 Oct 2026 | TD Cowen | BUY | $250.00 |
| 21 Oct 2026 | J.P. Morgan | BUY | – |
| 19 Oct 2026 | BofA Securities | BUY | $264.00 |
暂无评论——快来第一个聊聊 RVMD。
登录后参与讨论。